SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Hugo-Cesar Baggio, Bàrbara Segura, Roser Sala-Llonch, Maria-José Marti, Francesc Valldeoriola, Yaroslau Compta, Eduardo Tolosa, Carme Junqué, Cognitive impairment and resting-state network connectivity in Parkinson's disease, Human Brain Mapping, 2015, 36, 1
  2. 2
    Jeremy Cosgrove, Jane Elizabeth Alty, Stuart Jamieson, Cognitive impairment in Parkinson's disease, Postgraduate Medical Journal, 2015, 91, 1074, 212

    CrossRef

  3. 3
    Daniel Weintraub, Tanya Simuni, Chelsea Caspell-Garcia, Christopher Coffey, Shirley Lasch, Andrew Siderowf, Dag Aarsland, Paolo Barone, David Burn, Lama M. Chahine, Jamie Eberling, Alberto J. Espay, Eric D. Foster, James B. Leverenz, Irene Litvan, Irene Richard, Matthew D. Troyer, Keith A. Hawkins, Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease, Movement Disorders, 2015, 30, 7
  4. 4
    M. T. Pellecchia, M. Picillo, G. Santangelo, K. Longo, M. Moccia, R. Erro, M. Amboni, C. Vitale, C. Vicidomini, M. Salvatore, P. Barone, S. Pappatà, Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study, Acta Neurologica Scandinavica, 2015, 131, 5
  5. 5
    J. Michely, L. J. Volz, M. T. Barbe, F. Hoffstaedter, S. Viswanathan, L. Timmermann, S. B. Eickhoff, G. R. Fink, C. Grefkes, Dopaminergic modulation of motor network dynamics in Parkinson's disease, Brain, 2015, 138, 3, 664

    CrossRef

  6. 6
    Lindsey G. McIntosh, Sishir Mannava, Corrie R. Camalier, Bradley S. Folley, Aaron Albritton, Peter E. Konrad, David Charles, Sohee Park, Joseph S. Neimat, Emotion recognition in early Parkinson’s disease patients undergoing deep brain stimulation or dopaminergic therapy: a comparison to healthy participants, Frontiers in Aging Neuroscience, 2015, 6,

    CrossRef

  7. 7
    Anderson H.F.F. Leão, Aldair J. Sarmento-Silva, José R. Santos, Alessandra M. Ribeiro, Regina H. Silva, Molecular, Neurochemical, and Behavioral Hallmarks of Reserpine as a Model for Parkinson's Disease: New Perspectives to a Long-Standing Model, Brain Pathology, 2015, 25, 4
  8. 8
    M. Vikdahl, M.E. Domellöf, L. Forsgren, L. Håglin, Olfactory function, eating ability, and visceral obesity associated with MMSE three years after Parkinson’s disease diagnosis, The journal of nutrition, health & aging, 2015,

    CrossRef

  9. 9
    Valentina Varalta, Alessandro Picelli, Cristina Fonte, Stefania Amato, Camilla Melotti, Vanja Zatezalo, Leopold Saltuari, Nicola Smania, Relationship between Cognitive Performance and Motor Dysfunction in Patients with Parkinson’s Disease: A Pilot Cross-Sectional Study, BioMed Research International, 2015, 2015, 1

    CrossRef

  10. 10
    John V. Hindle, Anthony Martyr, Linda Clare, Cognitive reserve in Parkinson's disease: A systematic review and meta-analysis, Parkinsonism & Related Disorders, 2014, 20, 1, 1

    CrossRef

  11. 11
    Brandon R. Barton, Bryan Bernard, Virginie Czernecki, Jennifer G. Goldman, Glenn Stebbins, Bruno Dubois, Christopher G. Goetz, Comparison of the Movement Disorder Society Parkinson's disease dementia criteria with neuropsychological testing, Movement Disorders, 2014, 29, 10
  12. 12
    Bàrbara Segura, Hugo César Baggio, Maria Josep Marti, Francesc Valldeoriola, Yaroslau Compta, Anna Isabel Garcia-Diaz, Pere Vendrell, Núria Bargallo, Eduardo Tolosa, Carme Junque, Cortical thinning associated with mild cognitive impairment in Parkinson's disease, Movement Disorders, 2014, 29, 12
  13. 13
    Hugo-Cesar Baggio, Roser Sala-Llonch, Bàrbara Segura, Maria-José Marti, Francesc Valldeoriola, Yaroslau Compta, Eduardo Tolosa, Carme Junqué, Functional brain networks and cognitive deficits in Parkinson's disease, Human Brain Mapping, 2014, 35, 9
  14. 14
    C. Nombela, J. B. Rowe, S. E. Winder-Rhodes, A. Hampshire, A. M. Owen, D. P. Breen, G. W. Duncan, T. K. Khoo, A. J. Yarnall, M. J. Firbank, P. F. Chinnery, T. W. Robbins, J. T. O'Brien, D. J. Brooks, D. J. Burn, R. A. Barker, Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD study, Brain, 2014, 137, 10, 2743

    CrossRef

  15. 15
    Elke Kalbe, Annette Petrelli, Leichte kognitive Störungen und Demenz bei Patienten mit Morbus Parkinson, Zeitschrift für Neuropsychologie, 2014, 25, 1, 17

    CrossRef

  16. 16
    Mason Chin Pang Leung, Ka Keung Yip, Yuen Shan Ho, Flora Ka Wai Siu, Wai Chin Li, Belinda Garner, Mechanisms Underlying the Effect of Acupuncture on Cognitive Improvement: A Systematic Review of Animal Studies, Journal of Neuroimmune Pharmacology, 2014, 9, 4, 492

    CrossRef

  17. 17
    R. M. Villalba, T. Wichmann, Y. Smith, Neuronal loss in the caudal intralaminar thalamic nuclei in a primate model of Parkinson’s disease, Brain Structure and Function, 2014, 219, 1, 381

    CrossRef

  18. 18
    Jennifer G. Goldman, Ron Postuma, Premotor and nonmotor features of Parkinsonʼs disease, Current Opinion in Neurology, 2014, 27, 4, 434

    CrossRef

  19. 19
    Abhishek Jaywant, Giovanni Musto, Sandy Neargarder, Karina Stavitsky Gilbert, Alice Cronin-Golomb, The effect of Parkinson’s disease subgroups on verbal and nonverbal fluency, Journal of Clinical and Experimental Neuropsychology, 2014, 36, 3, 278

    CrossRef

  20. 20
    Nancy D. Chiaravalloti, Naroa Ibarretxe-Bilbao, John DeLuca, Olga Rusu, Javier Pena, Inés García-Gorostiaga, Natalia Ojeda, The source of the memory impairment in Parkinson's disease: Acquisition versus retrieval, Movement Disorders, 2014, 29, 6
  21. 21
    Jennifer G. Goldman, Caroline Williams-Gray, Roger A. Barker, John E. Duda, James E. Galvin, The spectrum of cognitive impairment in Lewy body diseases, Movement Disorders, 2014, 29, 5
  22. 22
    José R. Santos, João A.S. Cunha, Aline L. Dierschnabel, Clarissa L.C. Campêlo, Anderson H.F.F. Leão, Anatildes F. Silva, Rovena C.G.J. Engelberth, Geison S. Izídio, Jeferson S. Cavalcante, Vanessa C. Abílio, Alessandra M. Ribeiro, Regina H. Silva, Cognitive, motor and tyrosine hydroxylase temporal impairment in a model of parkinsonism induced by reserpine, Behavioural Brain Research, 2013, 253, 68

    CrossRef

  23. 23
    M. Kasten, J. Hagenah, J. Graf, A. Lorwin, E.-J. Vollstedt, E. Peters, A. Katalinic, H. Raspe, C. Klein, Cohort Profile: A population-based cohort to study non-motor symptoms in parkinsonism (EPIPARK), International Journal of Epidemiology, 2013, 42, 1, 128

    CrossRef

  24. 24
    Jennifer G. Goldman, Samantha Holden, Bryan Bernard, Bichun Ouyang, Christopher G. Goetz, Glenn T. Stebbins, Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease, Movement Disorders, 2013, 28, 14
  25. 25
    Philipp Mahlknecht, Werner Poewe, Defining premotor Parkinson’s disease: a window of opportunity for neuroprotection?, Neurodegenerative Disease Management, 2013, 3, 1, 61

    CrossRef

  26. 26
    Niklas Lenfeldt, William Hansson, Anne Larsson, Lars Nyberg, Richard Birgander, Lars Forsgren, Diffusion tensor imaging and correlations to Parkinson rating scales, Journal of Neurology, 2013, 260, 11, 2823

    CrossRef

  27. 27
    Georg Dirnberger, Marjan Jahanshahi, Executive dysfunction in Parkinson's disease: A review, Journal of Neuropsychology, 2013, 7, 2
  28. 28
    B. Mollenhauer, F. Sixel-Döring, A. Storch, C. Schneider, R. Hilker, E. Kalbe, Früherkennung der Parkinson-Krankheit, Der Nervenarzt, 2013, 84, 8, 918

    CrossRef

  29. 29
    Rachel G. Gross, Emily Camp, Corey T. McMillan, Michael Dreyfuss, Delani Gunawardena, Philip A. Cook, Brianna Morgan, Andrew Siderowf, Howard I. Hurtig, Matthew B. Stern, Murray Grossman, Impairment of script comprehension in Lewy body spectrum disorders, Brain and Language, 2013, 125, 3, 330

    CrossRef

  30. 30
    Bernard Ravina, Dag Aarsland, Many roads lead to Parkinson's disease, Movement Disorders, 2013, 28, 2
  31. 31
    A. J. Yarnall, L. Rochester, D. J. Burn, Mild cognitive impairment in Parkinson's disease, Age and Ageing, 2013, 42, 5, 567

    CrossRef

  32. 32
    Chaorui Huang, Lisa D. Ravdin, Melissa J. Nirenberg, Panida Piboolnurak, Lawrence Severt, James S. Maniscalco, Lilja Solnes, Benjamin J. Dorfman, Claire Henchcliffe, Neuroimaging Markers of Motor and Nonmotor Features of Parkinson's Disease: An [18F]Fluorodeoxyglucose Positron Emission Computed Tomography Study, Dementia and Geriatric Cognitive Disorders, 2013, 35, 3-4, 183

    CrossRef

  33. 33
    Ji Sun Kim, Jinyoung Youn, Hyeeun Shin, Jin Whan Cho, Nonmotor Symptoms in Drug-Induced Parkinsonism and Drug-Naïve Parkinson Disease, The Canadian Journal of Neurological Sciences, 2013, 40, 01, 36

    CrossRef

  34. 34
    Magdalena E. Domellöf, Lars Forsgren, Eva Elgh, Persistence of associations between cognitive impairment and motor dysfunction in the early phase of Parkinson’s disease, Journal of Neurology, 2013, 260, 9, 2228

    CrossRef

  35. 35
    Álvaro Sánchez-Ferro, Julián Benito-León, Elan D. Louis, Alex J. Mitchell, José Antonio Molina-Arjona, Rocío Trincado, Alberto Villarejo, Félix Bermejo-Pareja, Rate of cognitive decline in premotor Parkinson's disease: A prospective study (NEDICES), Movement Disorders, 2013, 28, 2
  36. 36
    Fabio Morellini, Spatial memory tasks in rodents: what do they model?, Cell and Tissue Research, 2013, 354, 1, 273

    CrossRef

  37. 37
    Kathy Dujardin, Albert F.G. Leentjens, Carole Langlois, Anja J.H. Moonen, Annelien A. Duits, Anne-Sophie Carette, Alain Duhamel, The spectrum of cognitive disorders in Parkinson's disease: A data-driven approach, Movement Disorders, 2013, 28, 2
  38. 38
    Simone Goebel, Lubomir Atanassov, Günter Köhnken, H. Maximilian Mehdorn, Bernd Leplow, Understanding quantitative and qualitative figural fluency in patients with Parkinson’s disease, Neurological Sciences, 2013, 34, 8, 1383

    CrossRef

  39. 39
    Valerie E. Kelly, Alexis J. Eusterbrock, Anne Shumway-Cook, A Review of Dual-Task Walking Deficits in People with Parkinson's Disease: Motor and Cognitive Contributions, Mechanisms, and Clinical Implications, Parkinson's Disease, 2012, 2012, 1

    CrossRef

  40. 40
    Rwei-Ling Yu, Ruey-Meei Wu, Ming-Jang Chiu, Chun-Hwei Tai, Chin-Hsien Lin, Mau-Sun Hua, Advanced Theory of Mind in patients at early stage of Parkinson’s disease, Parkinsonism & Related Disorders, 2012, 18, 1, 21

    CrossRef

  41. 41
    Angela M. Lee, Erik B. Oleson, Leontien Diergaarde, Joseph F. Cheer, Tommy Pattij, Cannabinoids and value-based decision making: Implications for neurodegenerative disorders, Basal Ganglia, 2012, 2, 3, 131

    CrossRef

  42. 42
    Brandon Barton, David Grabli, Bryan Bernard, Virginie Czernecki, Jennifer G. Goldman, Glenn Stebbins, Bruno Dubois, Christopher G. Goetz, Clinical validation of movement disorder society–recommended diagnostic criteria for Parkinson's disease with dementia, Movement Disorders, 2012, 27, 2
  43. 43
    Iddo Magen, Sheila M. Fleming, Chunni Zhu, Eddie C. Garcia, Katherine M. Cardiff, Diana Dinh, Krystal De La Rosa, Maria Sanchez, Eileen Ruth Torres, Eliezer Masliah, J. David Jentsch, Marie-Françoise Chesselet, Cognitive deficits in a mouse model of pre-manifest Parkinson’s disease, European Journal of Neuroscience, 2012, 35, 6
  44. 44
    Urban Ekman, Johan Eriksson, Lars Forsgren, Susanna Jakobson Mo, Katrine Riklund, Lars Nyberg, Functional brain activity and presynaptic dopamine uptake in patients with Parkinson's disease and mild cognitive impairment: a cross-sectional study, The Lancet Neurology, 2012, 11, 8, 679

    CrossRef

  45. 45
    Ronald B. Postuma, Dag Aarsland, Paolo Barone, David J. Burn, Christopher H. Hawkes, Wolfgang Oertel, Tjalf Ziemssen, Identifying prodromal Parkinson's disease: Pre-Motor disorders in Parkinson's disease, Movement Disorders, 2012, 27, 5
  46. 46
    Naroa Ibarretxe-Bilbao, Carme Junque, Barbara Segura, Hugo C. Baggio, Maria J. Marti, Francesc Valldeoriola, Nuria Bargallo, Eduardo Tolosa, Progression of cortical thinning in early Parkinson's disease, Movement Disorders, 2012, 27, 14
  47. 47
    Sarah Vanhoutte, Miet De Letter, Paul Corthals, John Van Borsel, Patrick Santens, Quantitative analysis of language production in Parkinson's disease using a cued sentence generation task, Clinical Linguistics & Phonetics, 2012, 26, 10, 863

    CrossRef

  48. 48
    Rachel G. Gross, Corey T. McMillan, Keerthi Chandrasekaran, Michael Dreyfuss, Sharon Ash, Brian Avants, Philip Cook, Peachie Moore, David J. Libon, Andrew Siderowf, Murray Grossman, Sentence processing in Lewy body spectrum disorder: The role of working memory, Brain and Cognition, 2012, 78, 2, 85

    CrossRef

  49. 49
    K. Wu, D. O'Keeffe, M. Politis, G. C. O'Keeffe, T. W. Robbins, S. K. Bose, D. J. Brooks, P. Piccini, R. A. Barker, The catechol-O-methyltransferase Val158Met polymorphism modulates fronto-cortical dopamine turnover in early Parkinson's disease: a PET study, Brain, 2012, 135, 8, 2449

    CrossRef

  50. 50
    Ulla Ellfolk, Salla Huurinainen, Juho Joutsa, Mira Karrasch, The Effect of Encoding Condition on Free Recall in Parkinson's Disease: Incidental and Intentional Memory are Equally Affected, The Clinical Neuropsychologist, 2012, 26, 6, 909

    CrossRef

  51. 51
    Naroa Ibarretxe-Bilbao, Carme Junque, Maria J. Marti, Eduardo Tolosa, Brain structural MRI correlates of cognitive dysfunctions in Parkinson's disease, Journal of the Neurological Sciences, 2011, 310, 1-2, 70

    CrossRef

  52. 52
    Paulo Bugalho, José Vale, Brief Cognitive Assessment in the Early Stages of Parkinson Disease, Cognitive And Behavioral Neurology, 2011, 24, 4, 169

    CrossRef

  53. 53
    A. H. V. Schapira, Challenges to the development of disease-modifying therapies in Parkinson’s disease, European Journal of Neurology, 2011, 18,
  54. 54
    Nele Verreyt, Gudrun M. S. Nys, Patrick Santens, Guy Vingerhoets, Cognitive Differences Between Patients with Left-sided and Right-sided Parkinson’s Disease. A Review, Neuropsychology Review, 2011, 21, 4, 405

    CrossRef

  55. 55
    Walter Glannon, Diminishing and Enhancing Free Will, AJOB Neuroscience, 2011, 2, 3, 15

    CrossRef

  56. 56
    Naroa Ibarretxe-Bilbao, Mojtaba Zarei, Carme Junque, Maria Jose Marti, Barbara Segura, Pere Vendrell, Francesc Valldeoriola, Nuria Bargallo, Eduardo Tolosa, Dysfunctions of cerebral networks precede recognition memory deficits in early Parkinson's disease, NeuroImage, 2011, 57, 2, 589

    CrossRef

  57. 57
    Elena Herrera, Fernando Cuetos, Javier Rodríguez-Ferreiro, Emotion recognition impairment in Parkinson's disease patients without dementia, Journal of the Neurological Sciences, 2011, 310, 1-2, 237

    CrossRef

  58. 58
    Anne-Isabelle Gasser, Elke Kalbe, Pasquale Calabrese, Josef Kessler, Geneviève Von Allmen, Philippe Rossier, French translation and normation of the Parkinson neuropsychometric dementia assessment (PANDA), Journal of the Neurological Sciences, 2011, 310, 1-2, 189

    CrossRef

  59. 59
    Irene Litvan, Dag Aarsland, Charles H. Adler, Jennifer G. Goldman, Jaime Kulisevsky, Brit Mollenhauer, Maria C. Rodriguez-Oroz, Alexander I. Tröster, Daniel Weintraub, MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD-MCI, Movement Disorders, 2011, 26, 10
  60. 60
    Michele Poletti, Murat Emre, Ubaldo Bonuccelli, Mild cognitive impairment and cognitive reserve in Parkinson’s disease, Parkinsonism & Related Disorders, 2011, 17, 8, 579

    CrossRef

  61. 61
    Dag Aarsland, Kolbjørn Brønnick, Tormod Fladby, Mild Cognitive Impairment in Parkinson’s Disease, Current Neurology and Neuroscience Reports, 2011, 11, 4, 371

    CrossRef

  62. 62
    Daniel Weintraub, David J. Burn, Parkinson's disease: The quintessential neuropsychiatric disorder, Movement Disorders, 2011, 26, 6
  63. 63
    Julián Benito-León, Elan D. Louis, Ignacio J. Posada, Álvaro Sánchez-Ferro, Rocío Trincado, Alberto Villarejo, Alex J. Mitchell, Félix Bermejo-Pareja, Population-based case–control study of cognitive function in early Parkinson's disease (NEDICES), Journal of the Neurological Sciences, 2011, 310, 1-2, 176

    CrossRef

  64. 64
    Álvaro Sánchez-Ferro, Julián Benito-León, Alex J. Mitchell, Elan D. Louis, Ignacio J. Posada, Rocío Trincado, Alberto Villarejo, Félix Bermejo-Pareja, Premotor cognitive status in a cohort of incident Parkinson disease patients (NEDICES), Journal of the Neurological Sciences, 2011, 310, 1-2, 211

    CrossRef

  65. 65
    A. H. V. Schapira, The management of Parkinson’s disease – what is new?, European Journal of Neurology, 2011, 18,
  66. 66
    Magdalena Eriksson Domellöf, Eva Elgh, Lars Forsgren, The relation between cognition and motor dysfunction in drug-naive newly diagnosed patients with Parkinson's disease, Movement Disorders, 2011, 26, 12
  67. 67
    Stanley Fahn, Joseph Jankovic, Mark Hallett, Principles and Practice of Movement Disorders, 2011,

    CrossRef

  68. 68
    Javier Rodríguez-Ferreiro, Fernando Cuetos, Elena Herrera, Manuel Menéndez, Renée Ribacoba, Cognitive impairment in Parkinson's disease without dementia, Movement Disorders, 2010, 25, 13
  69. 69
    Neurology in the European Journal of Neurology, European Journal of Neurology, 2010, 17, 12
  70. 70
    Maria C Rodriguez-Oroz, Marjan Jahanshahi, Paul Krack, Irene Litvan, Raúl Macias, Erwan Bezard, José A Obeso, Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms, The Lancet Neurology, 2009, 8, 12, 1128

    CrossRef

  71. 71
    Kurt A. Jellinger, Parkinson's Disease,